COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITP

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02566603
Recruitment Status : Terminated (Enough data has been collected to allow analysis of the safety profile and risk-benefit.)
First Posted : October 2, 2015
Last Update Posted : March 25, 2019
Information provided by (Responsible Party):
Protalex, Inc.

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : May 17, 2018
Actual Study Completion Date : May 17, 2018